SAM
RDY icon

Symphony Asset Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Symphony Asset Management’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-31,830
Closed -$294K – 421
2015
Q4 		$294K Sell
31,830
-15,285
-32% -$167K 0.03% 371
2015
Q3 		$602K Buy
+47,115
New +$585K 0.07% 275

Other funds holding RDY

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VAM
Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Symphony Asset Management's RDY Position: Q1 2016 in Review

Symphony Asset Management sold out of Dr. Reddy's Laboratories (RDY) in Q1 2016, closing a stake of 31,830 shares — an estimated $294K sold.

Symphony Asset Management first reported a position in RDY in Q3 2015 and held it in 2 quarters. The position peaked at $602K in Q3 2015. 160 funds tracked by Wall St. Rank hold RDY as of Q1 2016.

  • Symphony Asset Management reported no remaining Dr. Reddy's Laboratories position as of Q1 2016 after selling out during the quarter.
  • Symphony Asset Management sold 31,830 Dr. Reddy's Laboratories shares in Q1 2016, an estimated $294K.
  • Symphony Asset Management first reported a position in Dr. Reddy's Laboratories in Q3 2015 and held it in 2 quarters.
  • Symphony Asset Management's Dr. Reddy's Laboratories position peaked at $602K in Q3 2015.
  • 160 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2016.

Based on Symphony Asset Management's 13F filing for Q1 2016, filed 13 May 2016.